Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123935423 | 12393542 | 3 | F | 201503 | 20160704 | 20160523 | 20160708 | EXP | PHHY2016MX070146 | NOVARTIS | 89.72 | YR | F | Y | 0.00000 | 20160708 | CN | COUNTRY NOT SPECIFIED | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123935423 | 12393542 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 18 MG / EXELON 10 CM2 PATCH (9.5 MG, QD) | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 123935423 | 12393542 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | 22083 | TRANS-THERAPEUTIC-SYSTEM | |||||||||||
| 123935423 | 12393542 | 3 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Unknown | 1 DF, BID (IN MORNING AND AT NIGHT), STARTED 4 YEARS AGO | 0 | 1 | DF | TABLET | BID | ||||||
| 123935423 | 12393542 | 4 | C | MICARDIS | TELMISARTAN | 1 | Oral | 1 DF, QD (AT NIGHT) | 0 | 1 | DF | TABLET | QD | ||||||
| 123935423 | 12393542 | 5 | C | BETAHISTINE | BETAHISTINE | 1 | Unknown | 24 MG, UNK (STARTED 2 YEARS AGO) | 0 | 24 | MG | ||||||||
| 123935423 | 12393542 | 6 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Oral | 0.5 DF, QW4 (MONDAY, TUESDAY, WEDNESDAY, FRIDAY) | 0 | .5 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123935423 | 12393542 | 1 | Cerebral disorder |
| 123935423 | 12393542 | 2 | Senile dementia |
| 123935423 | 12393542 | 3 | Prophylaxis |
| 123935423 | 12393542 | 4 | Dizziness |
| 123935423 | 12393542 | 5 | Tinnitus |
| 123935423 | 12393542 | 6 | Oedema peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123935423 | 12393542 | HO |
| 123935423 | 12393542 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123935423 | 12393542 | Blood glucose increased | |
| 123935423 | 12393542 | Diabetes mellitus | |
| 123935423 | 12393542 | Product use issue | |
| 123935423 | 12393542 | Respiratory arrest | |
| 123935423 | 12393542 | Respiratory failure | |
| 123935423 | 12393542 | Urosepsis | |
| 123935423 | 12393542 | Vaginal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123935423 | 12393542 | 1 | 201503 | 20151223 | 0 | |
| 123935423 | 12393542 | 4 | 201509 | 0 | ||
| 123935423 | 12393542 | 6 | 201506 | 201512 | 0 |